Stay updated with breaking news from Rusty Montgomery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A team led by Naftali Kaminski, MD, used a newly designed molecule, called MRG-229, with potential therapeutic implications for idiopathic pulmonary fibrosis.
Family of NLRP3 inhibitors is differentiated by novel structure, central nervous system penetration, and potential for improved safety and efficacyRICHMOND, Calif.--(BUSINESS WIRE)--#aging--BioAge Labs, Inc. (“BioAge”), a privately held clinical-stage biotechnology company developing therapeutics that target the mol...